This leaflet is about the use of inhaled beclometasone inhaler for asthma. It is taken regularly in order to prevent attacks. (This is sometimes called asthma prophylaxis.)
This leaflet has been written specifically about the use of this medicine in children. The information may differ from that provided by the manufacturer. Please read this leaflet carefully. Keep it somewhere safe so that you can read it again.
Beclometasone inhalers should not be used during an acute asthma attack (sudden onset of wheezing and breathlessness). Use your child’s reliever medicine (usually a blue salbutamol inhaler).
Beclometasone dipropionate (often known as beclometasone for short)
It comes in a variety of different aerosol and dry powder inhalers, which have different brand names.
Beclometasone is a steroid medicine. It reduces inflammation in the lungs that can act as a trigger for an asthma attack, and so should reduce the number of attacks. Beclometasone is commonly called a ‘preventer’ medicine and comes in a brown inhaler. It is important that your child takes it regularly to help prevent asthma attacks.
Beclometasone will not reduce wheezing or breathlessness during an acute asthma attack – your child should use their ‘reliever’ inhaler for this (this is often a blue salbutamol inhaler).
Beclometasone has to be inhaled into the lungs (breathed in). A special device called an inhaler is used. There are two types of inhaler used for beclometasone.
Different sizes are available, which give puffs containing 50, 100 or 200 micrograms of beclometasone.
Beclometasone is usually given twice each day, once in the morning and once in the evening. Ideally, these times are 10–12 hours apart, for example some time between 7 and 8 am, and between 7 and 8 pm.
Give the medicine at about the same time(s) each day so that this becomes part of your child’s daily routine, which will help you to remember.
Your doctor will work out the amount of beclometasone (the dose) that is right for your child. The dose will be shown on the medicine label.
It is important that you follow your doctor’s instructions about how much to give.
This section provides instructions on how to use the beclometasone inhalers. An instruction leaflet will also be provided with the inhaler. This will tell you how to put the inhaler together and how to use it.
If you are not sure whether you are using the inhaler properly, or need help, contact your asthma nurse or pharmacist, who will be able to show you or check what you are doing.
Using an aerosol inhaler with a ‘spacer’ deviceThere are many different types of dry-powder inhaler. These are not used with a spacer.
Follow the instructions that come with your inhaler for how to get it ready. If you are not sure how to do this, ask your pharmacist or nurse to show you.
Beclometasone needs to be given regularly to prevent asthma and wheeze. Your child should start to wheeze less, and to need less reliever medicine, 3–7 days after starting treatment. Continue to give the medicine, as told to by your doctor or nurse, even if your child does not have any wheeze or symptoms of asthma.
If your child’s asthma does not seem to be getting any better, and they still need to use their reliever medicine often, contact your doctor or asthma nurse.
If your child is sick at any time, you do not need to give them another dose, as the inhaled medicine will still work.
If you remember up to 4 hours after you should have given a dose, give your child the missed dose. For example, if you usually give a dose at about 7 am, you can give the missed dose at any time up to 11 am. If you remember after that time, do not give the missed dose. Wait until the next normal dose.
Never give a double dose of beclometasone, unless your doctor has told you to.
Beclometasone is unlikely to cause harm if your child accidentally has more puffs than your doctor has recommended.
If you are worried that you may have given your child too much, contact your doctor or NHS Direct (0845 4647 in England and Wales; 08454 24 24 in Scotland) for advice. Have the inhaler or packaging with you if you telephone for advice.
We use medicines to make our children better, but sometimes they have other effects that we don’t want (side-effects).
If your child is taking a high dose of beclometasone, they may develop a yeast infection in the mouth, called oral thrush. If you notice a thick white or cream-coloured covering on your child’s tongue, or the mouth is red and irritated, contact your doctor for advice, as this may need treatment. You can help prevent this by making sure that your child rinses their mouth after using beclometasone, and by using a spacer device.
There may, sometimes, be other side-effects that are not listed above. If you notice anything unusual and are concerned, contact your doctor.
If your child becomes very unwell or requires an operation whilst on beclometasone, tell the doctors that your child uses a beclometasone inhaler.
In a very few cases, children become very unwell when they stop or reduce the amount of any steroid medicine they are taking, including beclometasone (in high doses). If you are at all worried about this, contact your doctor.
Your child’s doctor, pharmacist or asthma nurse will be able to give you more information about beclometasone and about other medicines used to treat asthma.
31/1/2012
Version 1.2, January 2012. © NPPG, RCPCH and WellChild 2011, all rights reserved. Reviewed by: January 2014.
The primary source for the information in this leaflet is the British National Formulary for Children. For details on any other sources used for this leaflet, please contact us through our website, www.medicinesforchildren.org.uk.
We take great care to make sure that the information in this leaflet is correct and up-to-date. However, medicines can be used in different ways for different patients. It is important that you ask the advice of your doctor or pharmacist if you are not sure about something. This leaflet is about the use of these medicines in the UK, and may not apply to other countries. The Royal College of Paediatrics and Child Health (RCPCH), the Neonatal and Paediatric Pharmacists Group (NPPG), WellChild and the contributors and editors cannot be held responsible for the accuracy of information, omissions of information, or any actions that may be taken as a consequence of reading this leaflet.